Yunik-Tech 2025: The portfolio improved on paper, but the partnership is still buying time

Getting To Know The Company

Yunik-Tech is not a technology operating company in the usual sense. It is a public limited partnership that holds very small minority positions in private technology companies, mostly through secondary transactions. That distinction matters. Its economics are not built on its own revenue, gross margin, and customers. They are built on three different engines: revaluation of holdings, actual realizations, and the ability to fund the waiting period until those realizations arrive.

What is working right now? The portfolio itself does not look frozen. At the end of 2025 the partnership held stakes in 8 companies, 6 of them unicorns, and reported financial assets of $ 3.586 million. Several of the key companies in the portfolio kept improving operationally: Motive moved from an annual sales pace of $ 370 million to $ 501 million, Dataminr from $ 222 million to $ 261 million, Dialpad from $ 324 million to $ 360 million, and BigID from $ 139 million to $ 159 million. At the partnership level, 2025 also brought a $ 404 thousand fair-value gain, and equity rose to $ 4.122 million.

But this is exactly where a first read can mislead. The partnership itself still has not proven a self-funding economic model. It ended the year with zero cash and cash equivalents, only $ 543 thousand in short-term investments, operating cash burn of $ 615 thousand, and general and administrative expenses of $ 847 thousand. Even if the entire short-term investment balance is treated as readily available liquidity, it is still below annual overhead and only slightly below one full year of 2025 operating cash burn.

That is the active bottleneck. Yunik-Tech is not at a stage where it is opening a new deployment chapter. It is at a stage where it has to prove that the value marked on paper can turn into cash without repeatedly diluting unit holders. The fact that $ 329 thousand in 2025 was recorded as a controlling-shareholder benefit because salary and management fees were not paid in cash, and that this reduction mechanism was extended into 2026 and even 2027, says something simple: the partnership is still buying time.

The practical-actionability layer is not clean either. In July 2025 the partnership received a warning that it was not meeting TASE preservation rules. In January 2026 it was told that it still did not meet the minimum public-holdings-value requirement, but qualified for regulatory relief and therefore would not be moved to the preservation list. On top of that, in the latest market snapshot the unit traded at 102.4 agorot with daily turnover of only NIS 23, while the Series 2 warrant exercise price is NIS 1.2. This is not just a small security. It is a real actionability constraint.

The economic map at the end of 2025 looks like this:

This chart matters because it breaks the temptation to think in terms of one portfolio number. Yunik-Tech is not truly diversified. Four holdings alone carry almost all the value. So even when the portfolio is presented as one line item, the thesis is really leaning on very few names and very few possible realization windows.

Events And Triggers

2025 lengthened the exit clock instead of shortening it

One of the most important moves of the year did not come through the income statement. It came through policy. In April and May 2025 the general meeting approved an extension of the IPO criterion: instead of expecting a target company to reach an IPO within up to 3 years of the original purchase, the framework was stretched to up to 5 years, and if there is still no IPO or public draft prospectus, the partnership is supposed to sell the full position within 63 months from the acquisition date.

That may sound technical, but it is not technical at all. It means the partnership itself effectively admitted that the original route to liquidity was too optimistic. Anyone who reads 2025 only through fair-value gains misses the fact that the company moved the clock outward.

There were realizations, but not realizations that reset the picture

In January 2025 the partnership completed the sale of the remaining SambaNova holding, 6,731 shares, at $ 34.5 per share for total consideration of $ 232 thousand. In November 2025 it completed the sale of the full Malwarebytes position, 7,617 shares, at $ 10.49 per share for total consideration of $ 79,970. In March 2025 it also participated pro rata in Indigo's round and invested $ 15,701 for 10,330 AA-1 preferred shares.

Those moves do matter, but they did not change the balance of the story. SambaNova and Malwarebytes exited the portfolio, Indigo got a small follow-on, but the cash position and funding flexibility were not reset. After all of this, the partnership still sat on a very narrow liquidity bridge and remained heavily dependent on the next realization window being bigger and faster.

The 2025 rights issue and the January 2026 offering were bridge financings, not growth capital

In September 2025 the partnership completed a rights issue that brought in $ 496 thousand net and issued 1,849,513 participation units plus 887,776 Series 2 warrants. In January 2026 it came back to the market again, this time through a new shelf-offering report, and issued 188,700 participation units and 94,350 additional Series 2 warrants for net proceeds of only $ 49 thousand.

The most important detail in the January 2026 shelf offering is not the size of the raise but the use of proceeds: the money is earmarked for ongoing operations only, not for new target-company investments. That is a short sentence, but it changes the angle of the whole year. 2026 does not open here as a fresh deployment year. It opens as a funding year.

This chart sharpens a basic point: even without classic bank debt, Yunik-Tech's capital structure is already behaving like a pressured one. The unit count jumped, the warrant layer thickened, and every future funding solution now runs through the unit price and the market's willingness to provide more capital.

The February-March 2026 warrant extension bought time around Motive

In February 2026 the partnership asked the court to extend the final exercise date of the Series 2 warrants to September 15, 2026. In the filing itself the partnership explained that capital raised through warrant exercise is a cheaper route than a new prospectus-based offering, and that one of the main reasons for filing at that time was the possible window around Motive's IPO process, which according to late-2025 and early-2026 disclosures was meant to include marketing of the shares and a raise of about $ 600 million.

This needs to be read carefully. The partnership did not say the money would definitely come, and it explicitly said the outcome depended on factors outside its control. But the request still reveals something deeper: Motive is no longer just another name in the portfolio. It has become a possible funding catalyst at the public-partnership level.

The problem is that this is still not a solution. The warrant exercise price is NIS 1.2, while the unit price in the latest market snapshot stood at 102.4 agorot. In other words, even after the extension, the warrants are still out of the money. The extension bought time, not value.

Efficiency, Profitability And Competition

The portfolio companies improved, but the public vehicle did not move anywhere close to clean economics

This is one of the key paradoxes in the report. Several companies inside the portfolio continued to show meaningful operating progress:

That chart can easily tempt the reader into concluding that the partnership is in much better shape. In one sense that is true: the companies carrying much of the value are not standing still. But at the Yunik-Tech public-vehicle level there is still no straight line from this growth to value that is accessible for unit holders. The partnership holds tiny percentages, each investment is less than 1% of the target company's capital, and it does not control exit timing or the route to monetization.

So a correct reading of 2025 has to hold two ideas at once: first, the portfolio does not look dead; second, this is still not proof that the partnership knows how to translate operating progress at the target-company level into cash at its own level.

The 2025 fair-value gain was narrow and concentrated

The fair-value gain for 2025 was $ 404 thousand. That is the headline number. But the internal breakdown tells a much sharper story:

Only three holdings, BigID, Dataminr, and Motive, contributed a combined $ 537 thousand, more than the entire annual fair-value gain. Mapbox alone offset $ 160 thousand of that. In other words, this was not a broad-based uplift across the whole portfolio. It was a relatively narrow improvement in a few large names that covered weakness elsewhere.

Even more important is the way that improvement was measured. The valuation appendix attached to the annual report does not set value mainly through fresh financing rounds in each company or through deep and recent market transactions. It relies mainly on relevant public-equity reference indices and measures how those indices moved from the acquisition date through the end of 2025. That is a legitimate methodology, but it also means something simple: the NAV improvement is not proof of liquidity, not proof of executed transaction pricing, and not proof of value already accessible to the partnership.

The report itself warns that not every quote is a market

The partnership explicitly states that it does not use quotes from secondary-trading platforms as the basis for fair value. The reason is clear: those platforms are not active markets, trading volumes are thin, and some of the numbers are only indications rather than completed transactions. That looks like a technical accounting note, but it is actually the center of the thesis.

If there is no deep market, and if the official year-end marking itself leans mainly on reference indices, then the portfolio can rise on paper while the route to turning that rise into cash remains narrow. This is not a classic moat story. It is a story about picking the right names and exiting at the right time.

That chart makes the broader picture clear. 2025 was indeed better than 2024, but even after fair-value gains turned positive again, the partnership still ended the year with a total loss of $ 425 thousand. In other words, even in a relatively good portfolio year, the expense and funding layers still did not disappear.

Cash Flow, Debt And Capital Structure

The right lens here is all-in cash flexibility

In Yunik-Tech's case, the central question is not how much the portfolio is worth, but how long the partnership can fund the waiting period until that value turns into actual cash. So the right frame is all-in cash flexibility, in other words what is left after the real cash uses of the period.

The 2025 numbers do not leave much room for interpretation. Operating cash flow was negative $ 615 thousand. Investing activity used a net $ 189 thousand, partly because of the Indigo follow-on and the move of liquidity into short-term investments. Financing activity supplied $ 496 thousand net from the rights issue. By year-end, cash itself was gone, and only $ 543 thousand remained in short-term investments.

That chart says almost everything. Even after the 2025 raise, and even if the full short-term balance is treated as liquid, the funding cushion still sits below annual overhead. The January 2026 offering added only $ 49 thousand net, which is less than 6% of 2025 G&A. So any argument that this is a "strong balance sheet" misses the point. Yunik-Tech is not pressured by debt. It is pressured by time.

There is no classic debt wall, but there is real capital-structure pressure

On the positive side, the partnership is not conventionally leveraged. Current liabilities at year-end stood at only $ 157 thousand. There is no large bank debt stack and no near-term amortization wall threatening to break the balance sheet. But במקום classic debt there is another form of pressure here: dilution.

At December 31, 2025 the partnership already had 887,776 tradable Series 2 warrants outstanding, and the financial liability recognized against them stood at $ 95 thousand. After the January 2026 offering, the tradable warrant count rose to 1,137,766. Alongside that, 138,468 non-tradable options were still outstanding. That means the future funding route now runs directly through the unit price and the ability to convert the warrant layer into real capital.

Support from the general partner is not a footnote

This point deserves its full name. Out of $ 847 thousand of general and administrative expenses in 2025, $ 329 thousand was not paid in cash and was instead recorded as a controlling-shareholder benefit. In 2024 the comparable figure was $ 473 thousand. Economically, this is not a small gesture. It is part of the partnership's survival mechanism.

The external warning signal is clear as well. The auditor drew explicit attention to the partnership's financial condition and to the expense-reduction plans. On top of that, the reduction and deferral mechanism was extended into 2026 and 2027, and in 2027 there is even a possible path to convert accumulated salary differences into participation units if cash-payment conditions are not met.

That is already more than flexibility. It is a funding layer in its own right, only not from a bank. So this too needs to be read correctly: it absolutely supports short-term flexibility, but it does not create a new recurring cash engine.

Guidance And What Comes Next

Before getting into 2026, four non-obvious points need to be locked down:

1. The companies inside the portfolio look healthier than the partnership that owns them.
2. The 2025 fair-value gain leaned on a few names and on a reference-index methodology, not on a wide set of clean realizations.
3. The 2025 and early-2026 capital raises were not designed to expand the portfolio. They were designed to keep the vehicle operating.
4. The warrant extension ties part of the near-term thesis to a single outside event, the Motive IPO window.

2026 looks like a funding bridge year, not a breakout year

This is the most important point. The partnership is not entering 2026 with a cash position that allows it to open a new investment chapter. It is entering 2026 with a need to turn paper value into actual liquidity. The test of 2026 is therefore a monetization test, not a presentation test.

What needs to happen for the reading to improve? First, at least one major holding needs to move from index-based marking to a real market anchor, an IPO, a financing round, or an actual sale. Second, the Motive window needs to advance for real. If the IPO process there matures, it could change the market's reading of the partnership, because the company itself has already tied the warrant extension to that event window. Third, the unit price needs to move back into a zone above the warrant strike. Otherwise even this bridge layer will not become real capital.

What the market may miss on a first read

The market can miss two opposite points here. On one side, it may see fair-value gains and higher equity again and assume that the situation has improved more than it really has. On the other side, it may focus only on tiny raises and very weak liquidity and miss the fact that several portfolio companies are still moving in the right operating direction.

That is why the coming year will not be judged through a generic "private unicorn exposure" story. It will be judged through a much narrower question: can Yunik-Tech finally show that there is a reasonable, not-too-dilutive path from calculated NAV to cash in the bank.

Risks

Valuation risk

This is the first risk because it sits at the center of the thesis. Most of the portfolio is marked using reference indices for relevant public equities. That gives a framework, but it is not a substitute for an active market or a fresh transaction. If technology-market sentiment changes, or if the chosen public comparables stop reflecting the profile of the private companies in the portfolio, NAV can move even without a single real monetization event.

Concentration risk

BigID, Dataminr, Mapbox, and Motive together account for about 87.1% of the portfolio's fair value. That means any disappointment, delay, weak round, or postponed IPO in one of those major names can quickly change the picture for the entire partnership.

Funding and dilution risk

The partnership may not sit under classic debt pressure, but it does sit under real equity pressure. More raises, more warrants, and possible future conversion of deferred salary balances into participation units can all extend the life of the partnership while still eroding existing unit holders.

Trading-liquidity and market-access risk

Daily turnover of only NIS 23 and a unit price still below the warrant strike are not side details. They say that the portfolio's theoretical value is still struggling to pass the market test. In that kind of setup even good news has to work harder in order to change the market's reading.

Conclusions

Yunik-Tech ended 2025 in a better place on paper, but not necessarily in a stronger place financially. The portfolio itself kept moving forward in several major names, and fair-value gains turned positive again. But at the public-partnership level the core story is still financial: too little liquidity, too much dependence on the equity market, and continued support from the general partner to carry the period until the next realization.

The current thesis in one line: Yunik-Tech owns a portfolio that may hold real value, but as of the end of 2025 the path from that value to unit holders still runs through revaluations, warrants, waivers from the general partner, and a realization window that has not really opened yet.

What changed versus the previous understanding of the company: the portfolio no longer looks frozen, and several of the key holdings do show operating progress. At the same time, the time structure of the thesis moved outward: the exit clock was extended, the warrant layer became larger, and even the January 2026 raise was meant only to fund ongoing operations.

The counter-thesis: one can argue that this reading is too cautious because the portfolio itself has improved, several of the major holdings continue to grow, and the U.S. IPO market may remain more open in 2026. If a meaningful liquidity event happens in one of the large holdings, Yunik-Tech could quickly look like a very small public vehicle with much larger embedded optionality than the market is currently pricing.

What may change the market reading in the short to medium term: real progress in the Motive IPO path or in another monetization event, a real market anchor for one of the key holdings rather than index-only marking, and a move back above the warrant strike. On the other hand, another delay in the monetization window or another small operating-only raise would harden the cautious reading.

Why this matters: in Yunik-Tech it is not enough to create value on paper. Investors need to see how that value becomes liquid, not too dilutive, and actually accessible at the public-partnership level. That is the real economic test of 2026.

What must happen over the next 2 to 4 quarters: at least one major holding needs to deliver a real liquidity event or a real market-value anchor, the Motive window needs to either advance or clearly stall, the warrants need to become economically relevant again, and the partnership needs to show that it can get through 2026 without coming back to the market for another small operating raise.